Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,841 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-carboxymethylchitosan-N,O-sulfate as an anti-HIV-1 agent.
Sosa MA, Fazely F, Koch JA, Vercellotti SV, Ruprecht RM. Sosa MA, et al. Among authors: koch ja. Biochem Biophys Res Commun. 1991 Jan 31;174(2):489-96. doi: 10.1016/0006-291x(91)91443-g. Biochem Biophys Res Commun. 1991. PMID: 1704225
Mucosal infection of neonatal rhesus monkeys with cell-free SIV.
Baba TW, Koch J, Mittler ES, Greene M, Wyand M, Penninck D, Ruprecht RM. Baba TW, et al. Among authors: koch j. AIDS Res Hum Retroviruses. 1994 Apr;10(4):351-7. doi: 10.1089/aid.1994.10.351. AIDS Res Hum Retroviruses. 1994. PMID: 8068415
Animal models for anti-AIDS therapy.
Koch JA, Ruprecht RM. Koch JA, et al. Antiviral Res. 1992 Aug;19(2):81-109. doi: 10.1016/0166-3542(92)90069-h. Antiviral Res. 1992. PMID: 1444326 Review.
Murine models for evaluating antiretroviral therapy.
Ruprecht RM, Bernard LD, Gama Sosa MA, Sosa MA, Fazely F, Koch J, Sharma PL, Mullaney S. Ruprecht RM, et al. Among authors: koch j. Cancer Res. 1990 Sep 1;50(17 Suppl):5618S-5627S. Cancer Res. 1990. PMID: 2167158 Review.
First-in-Human Phase 1 study of a CD16A bispecific innate cell engager, AFM24, targeting EGFR-expressing solid tumors.
El-Khoueiry A, Saavedra O, Thomas J, Livings C, Garralda E, Hintzen G, Kohlhas L, Vanosmael D, Koch J, Rajkovic E, Ravenstijn P, Nuciforo P, Fehniger TA, Foster M, Berrien-Elliott MM, Wingert S, Stäble S, Morales-Espinosa D, Rivas D, Emig M, Lopez J. El-Khoueiry A, et al. Among authors: koch j. Clin Cancer Res. 2025 Jan 23. doi: 10.1158/1078-0432.CCR-24-1991. Online ahead of print. Clin Cancer Res. 2025. PMID: 39846810
Long-term efficacy and tolerability of brivaracetam in pediatric patients with focal-onset seizures and cognitive or learning comorbidities: Post hoc analysis of an open-label trial.
Bourikas D, Koch J, de la Loge C, Dimova S, Elmoufti S, Moseley B, Lagae L. Bourikas D, et al. Among authors: koch j. Epilepsy Res. 2025 Jan;209:107482. doi: 10.1016/j.eplepsyres.2024.107482. Epub 2024 Dec 5. Epilepsy Res. 2025. PMID: 39637726 Free article. Clinical Trial.
1,841 results